DataString Consulting Company Logo
DataString Consulting Company Logo
Renal Failure Treatment Market
Home»Top Market Reports»Renal Failure Treatment Market

Renal Failure Treatment Market

Author: Debadatta Patel - Senior Consultant, Report ID - DS1801150, Published - March 2025

Segmented in Type (Dialysis, Kidney Transplant), Dialysis Method (Hemodialysis, Peritoneal, Continuous Renal Replacement Therapy), Transplant Procedure, Drug Therapy and Regions - Global Industry Analysis, Size, Share, Trends, and Forecast 2024 – 2034

Share this report:

Global Renal Failure Treatment Market Outlook

The market, for Renal failure treatment was estimated at $136.2 billion in 2024; and it is anticipated to increase to $219.7 billion by 2030 with projections indicating a growth to around $327.3 billion by 2035. This expansion represents a compound annual growth rate (CAGR) of 8.3% over the forecast period. The substantial growth of this market is fueled by factors including the increasing occurrence of chronic kidney diseases and conditions like diabetes and hypertension globally. Furthermore theindustry'sexpansion is being driven by progress in healthcare facilities and the adoption of innovative treatments, for renal failure. The growing number of individuals facing a higher likelihood of kidney problems and the increasing healthcare spending alongside patients becoming more informed about advanced treatment choices all play a role, in shaping the market trends and ensuring the ongoing importance of Renal Failure Treatment.


Treatment for kidney failure is undergoing advancements in therapeutic methods and medication strategies that are reshaping the field of medicine positively. The approach focuses on detecting kidney diseases and managing their progression effectively. Renal Replacement Therapy (RRT) dialysis treatments and kidney transplants are widely used in settings to address the growing need for these interventions, in healthcare.


Market Size Forecast & Key Insights

2019
$136B2024
2029
$302B2034

Absolute Growth Opportunity = $166B

The Renal Failure Treatment market is projected to grow from $136.2 billion in 2024 to $302 billion in 2034. This represents a CAGR of 8.3%, reflecting rising demand across Dialysis Treatment, Pharmacological Treatment and Kidney Transplant.

The Renal Failure Treatment market is set to add $166 billion between 2024 and 2034, with manufacturer targeting Peritoneal & Continuous Renal Replacement Therapy Dialysis Method projected to gain a larger market share.

With Rising prevalence of kidney diseases, and Technological advancements in renal treatment modalities, Renal Failure Treatment market to expand 122% between 2024 and 2034.

Opportunities in the Renal Failure Treatment Market

Therapeutic Advancements in Renal Failure Management

The medical field is placing emphasis on creating innovative drugs and treatments, for kidney failure treatment lately especially with the introduction of biologics and other cutting edge therapies aimed at slowing down the advancement of kidney disease, which could greatly impact the renal failure treatment market.

Technological Innovations in Dialysis and Strategic Collaborations to Boost Renal Failure Treatment

The increasing instances of kidney failure have created a valuable market for treatment due to advancements in dialysis technology like portable kidney devices and enhancements in hemodialysis machines that promise better treatment options and contribute to sector expansion. Additionally the use of tools, for monitoring patients remotely offers improved patient care and management solutions.

Collaborations and partnerships among firms, research institutions, medical device makers and healthcare IT companies have the potential to transform the treatment of renal failure through the integration of cutting edge technologies and methodologies. These partnerships could accelerate the development of treatments enhance patients access to state of the art care in various areas and stimulate substantial growth, in the market.

Growth Opportunities in North America and Europe

Europe Outlook

In Europe's renal failure treatment sector is bolstered by top notch healthcare facilities and extensive insurance coverage along with an aging population to kidney diseases Trends show a competitive market due to the presence of established international firms and up and coming local businesses Additionally there are abundant chances, for applying AI and ML in diagnosis monitoring patients and tailoring treatment strategies Advancements, in personalized healthcare are also influencing the market by providing customized treatments based on genetic profiles.

North America Outlook

North America plays a role in the renal failure treatment market with a focus on the United States due to improvements in healthcare facilities and increased awareness about kidney diseases and their management. Acknowledging the rising need for renal care solutions in the region leading providers are investing significantly in research and development to bring forth advanced treatment options, for renal failure. In spite of competition from well known companies that provide cutting edge technologies like dialysis equipment and pharmaceutical products there are market prospects, in the realm of kidney transplants by utilizing new immunosuppressive medications to enhance the procedures efficacy and safety.

North America Outlook

North America plays a role in the renal failure treatment market with a focus on the United States due to improvements in healthcare facilities and increased awareness about kidney diseases and their management. Acknowledging the rising need for renal care solutions in the region leading providers are investing significantly in research and development to bring forth advanced treatment options, for renal failure. In spite of competition from well known companies that provide cutting edge technologies like dialysis equipment and pharmaceutical products there are market prospects, in the realm of kidney transplants by utilizing new immunosuppressive medications to enhance the procedures efficacy and safety.

Europe Outlook

In Europe's renal failure treatment sector is bolstered by top notch healthcare facilities and extensive insurance coverage along with an aging population to kidney diseases Trends show a competitive market due to the presence of established international firms and up and coming local businesses Additionally there are abundant chances, for applying AI and ML in diagnosis monitoring patients and tailoring treatment strategies Advancements, in personalized healthcare are also influencing the market by providing customized treatments based on genetic profiles.

Growth Opportunities in North America and Europe

Established and Emerging Market's Growth Trend 2025–2034

1

Major Markets : United States, Germany, Japan, United Kingdom, China are expected to grow at 6.1% to 8.7% CAGR

2

Emerging Markets : Brazil, Indonesia, South Africa are expected to grow at 8.0% to 10.4% CAGR

Market Analysis Chart

Treating kidney failure involves medical interventions that aim to help the kidneys function normally again. The growing number of people needing treatment for kidney failure is primarily driven by the rise in cases of kidney diseases and the aging population worldwide. Chronic kidney disease often progresses to kidney failure and requires treatment. This health issue is commonly linked with individuals which contributes significantly to the demand for treatment, in this field.

Recent Developments and Technological Advancement

December 2024

NephroPlus introduced dialysis technology to improve their treatment options, for renal failure patients.

October 2024

The clinical trial findings for Da Vinci Kidney Cares treatment, for advanced kidney disease showed encouraging outcomes in delaying the advancement of renal failure.

August 2024

Fresh Medical Care introduced an artificial kidney as a major advancement in enhancing the treatment processes, for renal failure.

Treatment for kidney failure is a part of healthcare that has been improving lately due to advancements in medical technology leading to more effective solutions being introduced in the sector with a noticeable shift, towards non invasive procedures.

Impact of Industry Transitions on the Renal Failure Treatment Market

As a core segment of the Medical Device industry, the Renal Failure Treatment market develops in line with broader industry shifts. Over recent years, transitions such as Introduction of Dialysis Techniques and Advent of Renal Transplantation have redefined priorities across the Medical Device sector, influencing how the Renal Failure Treatment market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.

1

Introduction of Dialysis Techniques:

Renal failure treatment in medicine heavily relies on dialysis as a fundamental method. This groundbreaking technology has not only extended the lifespan and improved the quality of life for patients but has also fueled growth in related sectors. For example pharmaceutical companies focusing on mitigating dialysis related side effects and medical equipment manufacturers producing dialysis machines have experienced demand. Moreover the innovation has paved the way for the establishment of dialysis centers result in the creation of job opportunities, within the healthcare industry.

2

Advent of Renal Transplantation:

The introduction of kidney transplants has revolutionized the way we treat kidney failure in the field. In the organ transplants faced many challenges due to the bodys rejection and difficulties in finding donor kidneys. Thanks to advancements in surgery methods and medications that suppress the immune system kidney transplants are now a reliable and successful solution for those, with advanced kidney disease. The shift has resulted in the expansion of firms offering immunosuppressants and medical centers focusing on organ transplant services. Significantly influencing the healthcare sectors structure overall.

Global Events Shaping Future Growth

The chart below highlights how external events including emerging market developments, regulatory changes, and technological disruptions, have added another layer of complexity to the Medical Device industry. These events have disrupted supply networks, changed consumption behavior, and reshaped growth patterns. Together with structural industry transitions, they demonstrate how changes within the Medical Device industry cascade into the Renal Failure Treatment market, setting the stage for its future growth trajectory.

Market Dynamics and Supply Chain

Driver: Rising Prevalence of Kidney Diseases, and Increasing Investment in Research and Development

Kidney disease affects millions worldwide each year. The demand for effective treatments is also on the rise due to factors like high blood pressure and diabetes leading to renal failure treatment providers creating new solutions to meet the increasing needs of patients in this growing market, for chronic kidney disease treatments.
Nations and businesses worldwide are also dedicating resources to research and development efforts aimed at creating new and effective treatments, for kidney failure.
Medical technology has also significantly enhanced kidney transplant methods and dialysis procedures in the treatment of failure patients. This progress includes the development of portable dialysis machines and bio artificial kidneys well as enhancements in kidney transplant procedures. These advancements are also poised to deliver efficient and effective care for individuals with renal failure. This progress is also driving growth in the market for failure treatments, in particular those centered on technologically enhanced treatment options.

Restraint: High Treatment Costs

Despite the progress in technology managing kidney failure continues to be a heavy financial responsibility for numerous individuals. The expensive nature of dialysis kidney transplants and other treatments for failure can discourage potential patients especially in countries with restricted health insurance coverage like developing nations. This leads to a decrease in the demand, for treatments related to kidney failure, which in turn hinders the growth of the market.

Challenge: Lack of Awareness

There is a concerning lack of knowledge and comprehension regarding kidney failure and how it can be treated in areas of the world. A lot of people are unaware that they have kidney issues until its too late. This delay in recognizing the problem leads to a delay in getting the treatment on time which affects the demand, for kidney failure treatments globally and influences market growth dynamics.

Supply Chain Landscape

Research & Development

Pfizer Inc

Amgen Inc

Raw Material Procurement

Johnson & Johnson

Novartis AG

Production
Fresenius Medical Care / DaVita Inc
Distribution & end-users
CVS Health / AstraZeneca
Research & Development

Pfizer Inc

Amgen Inc

Raw Material Procurement

Johnson & Johnson

Novartis AG

Production

Fresenius Medical Care

DaVita Inc

Distribution & end-users

CVS Health

AstraZeneca

Banner LogoBanner Logo

Leading Providers and Their Strategies

Application AreaIndustryLeading Providers / ConsumersProvider Strategies
Dialysis Treatment
Healthcare
Fresenius Medical Care
Expansion of dialysis centres and advancements in technology
Kidney Transplantation
Medical
Novartis
Investment in research and development to improve the efficacy of immunosuppressive drugs
Drug Therapy
Pharmaceutical
AstraZeneca
Focusing on introducing innovative drug therapies with lesser side effects
Conservative Management
Healthcare
DaVita Inc.
Focus on preventive care and personalized treatment plans to slow the progression of renal failure

Elevate your strategic vision with in-depth analysis of key applications, leading market players, and their strategies. The report analyzes industry leaders' views and statements on the Renal Failure Treatment market's present and future growth.

Our research is created following strict editorial standards. See our Editorial Policy

Applications of Renal Failure Treatment in Pharmacological Treatment, Kidney Transplant and Dialysis Treatment

Pharmacological Treatment

Pharmacological therapies are commonly combined with approaches to address kidney failure effectively. This usually includes prescribing drugs such as angiotensin converting enzyme inhibitors and angiotensin II receptor blockers . An important contributor in the field of treatment is AstraZeneca offering beneficial remedies like sodium glucose co transporter 2 which play a significant role, in controlling diabetes related chronic kidney disease.

Kidney Transplant

Kidney transplantation is a way to address kidney failure by replacing a failing kidney with a healthy one donated by someone else. To avoid rejection of the organ by the bodys immune system after transplantation doctors often prescribe immunosuppressant medications. Novartis AG has established a presence in this medical field with medications such as Cyclosporine that are recognized for their effectiveness, in managing patients post transplantation.

Dialysis Treatment

Dialysis plays a role in treating kidney failure and relies mainly on two methods. Hemodialysis and peritoneal dialysis Hemodialysis utilizes a machine to cleanse the blood of toxins whereas peritoneal dialysis leverages the abdominal cavity lining for purification Among the top contenders in providing dialysis care Fresenius Medical Care AG & Co distinguishes itself with its cutting edge and patient centric dialysis solutions solidifying its position, as a market leader.

Renal Failure Treatment vs. Substitutes:
Performance and Positioning Analysis

Renal Failure Treatment, compared to its alternatives, features a more comprehensive approach targeting root causes, positioning it for significant potential growth in the healthcare industry. These Alternatives specially Wearable Artificial Kidney has experienced a rapid growth as detailed in our latest report.

Renal Failure Treatment
  • Wearable Artificial Kidney /
  • Kidney Transplant
    Proven effectiveness in managing disease symptoms, advancements in dialysis technology
    Limited access to treatment in remote areas, high cost of
    Effective in managing symptoms, One-time procedure
    Risks associated with invasive surgery, High costs

Renal Failure Treatment vs. Substitutes:
Performance and Positioning Analysis

Renal Failure Treatment

  • Proven effectiveness in managing disease symptoms, advancements in dialysis technology
  • Limited access to treatment in remote areas, high cost of

Wearable Artificial Kidney / Kidney Transplant

  • Effective in managing symptoms, One-time procedure
  • Risks associated with invasive surgery, High costs

Renal Failure Treatment, compared to its alternatives, features a more comprehensive approach targeting root causes, positioning it for significant potential growth in the healthcare industry. These Alternatives specially Wearable Artificial Kidney has experienced a rapid growth as detailed in our latest report.

Loading...

Research Methodology

This market research methodology defines the Renal Failure Treatment market scope, gathers reliable data, and validates findings using integrated primary and secondary research. Our systematic framework ensures precise market sizing, growth trend analysis, and competitive benchmarking.


Secondary Research Approach


We begin secondary research by defining the targeted market at Country and Regional levels. As part of the Medical Device ecosystem, we analyze Renal Failure Treatment across Dialysis and Kidney Transplant Applications. Our team gathers data systematically from country level ministerial sources, industry associations & federations, trade databases, company annual & quarterly reports and other credential sources, enabling us to map global and regional market size, pricing trends, regulatory standards, and technology advancements.


Key Sources Referenced:


We benchmark competitors such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, and DaVita Inc. by reviewing company financial statements, and regulatory filings. Our secondary insights identify key market drivers and constraints, forming the analytical foundation for primary research.


Primary Research Methods


We conduct structured interviews and surveys with industry stakeholders, including Research & Development, Raw Material Procurement, and Production. Our geographic coverage spans Americas (40%), Europe (30%), Asia-Pacific (25%) and Middle East & Africa (5%). Our online surveys generally achieve a response rate of above 65%, and telephone interviews yield 60%, resulting in above 92% confidence level with a ±7% margin of error.


Through targeted questionnaires and in-depth interviews, we capture purchase intent, adoption barriers, brand perception across Segment Type. We use interview guides to ensure consistency and anonymous survey options to mitigate response bias. These primary insights validate secondary findings and align market sizing with real-world conditions.


Market Engineering & Data Analysis Framework


Our data analysis framework integrates Top-Down, Bottom-Up, and Company Market Share approaches to estimate and project market size with precision.


Top-down & Bottom-Up Process


In Top-down approach, we disaggregate global Medical Device revenues to estimate the Renal Failure Treatment segment, using historical growth patterns to set baseline trends. Simultaneously, in Bottom-up approach, we aggregate Country-Level Demand Data to derive regional and global forecasts, which provide granular consumption insights. By reconciling both approaches, we ensure statistical precision and cross-validation accuracy.


We evaluate the supply chain, spanning Research & Development (Pfizer Inc, Amgen Inc), Raw Material Procurement (Johnson & Johnson, Novartis AG), and Production. Our parallel substitute analysis examines Wearable Artificial Kidney and Kidney Transplant, highlighting diversification opportunities and competitive risks.


Company Market Share & Benchmarking


We benchmark leading companies such as Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, and DaVita Inc., analyzing their capabilities in pricing, product features, technology adoption, and distribution reach. By assessing company-level revenues and product portfolios, we derive market share comparisons, clarifying competitive positioning and growth trajectories across the ecosystem.


Our integration of data triangulation, supply chain evaluation, and company benchmarking, supported by our proprietary Directional Superposition methodology enables us to deliver precise forecasts and actionable strategic insights into the Renal Failure Treatment market.


Quality Assurance and Compliance


We cross-reference secondary data with primary inputs and external expert reviews to confirm consistency. Further, we use stratified sampling, anonymous surveys, third-party interviews, and time-based sampling to reduce bias and strengthen our results.


Our methodology is developed in alignment with ISO 20252 standards and ICC/ESOMAR guidelines for research ethics. The study methodology follows globally recognized frameworks such as ISO 20252 and ICC codes of practice.

rm

Renal Failure Treatment Market Data: Size, Segmentation & Growth Forecast

Report AttributeDetails
Market Value in 2025USD 147 billion
Revenue Forecast in 2034USD 302 billion
Growth RateCAGR of 8.3% from 2025 to 2034
Base Year for Estimation2024
Industry Revenue 2024136 billion
Growth OpportunityUSD 166 billion
Historical Data2019 - 2023
Growth Projection / Forecast Period2025 - 2034
Market Size UnitsMarket Revenue in USD billion and Industry Statistics
Market Size 2024136 billion USD
Market Size 2027173 billion USD
Market Size 2029202 billion USD
Market Size 2030219 billion USD
Market Size 2034302 billion USD
Market Size 2035327 billion USD
Report CoverageMarket revenue for past 5 years and forecast for future 10 years, Competitive Analysis & Company Market Share, Strategic Insights & trends
Segments CoveredType, Dialysis Method, Transplant Procedure, Drug Therapy
Regional scopeNorth America, Europe, Asia Pacific, Latin America and Middle East & Africa
Country scopeU.S., Canada, Mexico, UK, Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE and South Africa
Companies ProfiledBaxter International Inc., Fresenius Medical Care AG & Co. KGaA, DaVita Inc., B. Braun Melsungen AG, Nipro Corporation, Medtronic plc, Asahi Kasei Corporation, Nikkiso Co. Ltd., Toray Medical Co. Ltd., Cantel Medical Corporation, Rockwell Medical and NxStage Medical Inc.
CustomizationFree customization at segment, region or country scope and direct contact with report analyst team for 10 to 20 working hours for any additional niche requirement which is almost equivalent to 10% of report value

Explore Report Features and Data Packages

Industry Insight Report

$ 4200
Unlock Multi-User Access for just $999 more
i
No Payment Before Report Delivery
Flexible Payment Options
Additional Features
Customization Available
i
Excel Data Pack Included
Free Analyst Support
i
Industry Expert-Validated Insights
100% Confidentiality Guaranteed
Fast Delivery (24–72 hours)
i
Get Report Now

Strategic Growth Advisory

Unrivaled Custom Market Intelligence & Strategic Advisory for Business Growth and Competitive Excellence

  • Assess and prioritize high-value markets with precision
  • Craft tailored entry and expansion roadmaps
  • De-risk investments through rigorous market intelligence
  • Architect dynamic pricing frameworks aligned to value creation
  • Unlock sustainable margin enhancement opportunities
  • Benchmark performance against global industry leaders
  • Strategically realign portfolios to future growth drivers
  • Accelerate commercialization of breakthrough offerings
  • Harness market foresight and technology shifts to fuel innovation

Discover our Strategic Growth Advisory Services »

Table of Contents

Industry Insights Report - Table Of Contents

Chapter 1

Executive Summary

Major Markets & Their Performance - Statistical Snapshots

Chapter 2

Research Methodology

2.1Axioms & Postulates
2.2Market Introduction & Research MethodologyEstimation & Forecast Parameters / Major Databases & Sources
Chapter 3

Market Dynamics

3.1Market OverviewDrivers / Restraints / Opportunities / M4 Factors
3.2Market Trends
3.2.1Introduction & Narratives
3.2.2Market Trends - Impact Analysis(Short, Medium & Long Term Impacts)
3.3Supply Chain Analysis
3.4Porter's Five ForcesSuppliers & Buyers' Bargaining Power, Threat of Substitution & New Market Entrants, Competitive Rivalry
Chapter 4

Renal Failure Treatment Market Size, Opportunities & Strategic Insights, by Type

4.1Dialysis
4.2Kidney Transplant
Chapter 5

Renal Failure Treatment Market Size, Opportunities & Strategic Insights, by Dialysis Method

5.1Hemodialysis
5.2Peritoneal
5.3Continuous Renal Replacement Therapy
Chapter 6

Renal Failure Treatment Market Size, Opportunities & Strategic Insights, by Transplant Procedure

6.1Deceased-Donor
6.2Living-Donor
Chapter 7

Renal Failure Treatment Market Size, Opportunities & Strategic Insights, by Drug Therapy

7.1Angiotensin-Converting Enzyme (Ace) Inhibitors
7.2Angiotensin II Receptor Blockers (Arbs)
Chapter 8

Renal Failure Treatment Market, by Region

8.1North America Renal Failure Treatment Market Size, Opportunities, Key Trends & Strategic Insights
8.1.1U.S.
8.1.2Canada
8.2Europe Renal Failure Treatment Market Size, Opportunities, Key Trends & Strategic Insights
8.2.1Germany
8.2.2France
8.2.3UK
8.2.4Italy
8.2.5The Netherlands
8.2.6Rest of EU
8.3Asia Pacific Renal Failure Treatment Market Size, Opportunities, Key Trends & Strategic Insights
8.3.1China
8.3.2Japan
8.3.3South Korea
8.3.4India
8.3.5Australia
8.3.6Thailand
8.3.7Rest of APAC
8.4Middle East & Africa Renal Failure Treatment Market Size, Opportunities, Key Trends & Strategic Insights
8.4.1Saudi Arabia
8.4.2United Arab Emirates
8.4.3South Africa
8.4.4Rest of MEA
8.5Latin America Renal Failure Treatment Market Size, Opportunities, Key Trends & Strategic Insights
8.5.1Brazil
8.5.2Mexico
8.5.3Rest of LA
8.6CIS Renal Failure Treatment Market Size, Opportunities, Key Trends & Strategic Insights
8.6.1Russia
8.6.2Rest of CIS
Chapter 9

Competitive Landscape

9.1Competitive Dashboard & Market Share Analysis
9.2Company Profiles (Overview, Financials, Developments, SWOT)
9.2.1Baxter International Inc.
9.2.2Fresenius Medical Care AG & Co. KGaA
9.2.3DaVita Inc.
9.2.4B. Braun Melsungen AG
9.2.5Nipro Corporation
9.2.6Medtronic plc
9.2.7Asahi Kasei Corporation
9.2.8Nikkiso Co. Ltd.
9.2.9Toray Medical Co. Ltd.
9.2.10Cantel Medical Corporation
9.2.11Rockwell Medical
9.2.12NxStage Medical Inc.